Proteus syndrome: Misdiagnosis with PTEN mutations

American Journal of Medical Genetics

Volumn 122 A, Issue 4, 2003, Pages 323-324

  Cohen Jr , M Michael ^a   Turner, Joyce T ^b   Biesecker, Leslie G ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

CLINICAL FEATURE; CONFERENCE PAPER; DIAGNOSTIC ERROR; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; MULTIPLE CANCER; PRIORITY JOURNAL;

DIAGNOSTIC ERRORS; HUMANS; PHOSPHORIC MONOESTER HYDROLASES; PROTEUS SYNDROME; PTEN PHOSPHOHYDROLASE; TUMOR SUPPRESSOR PROTEINS;

EID: 0141924714     PISSN: 15524825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Barker K, Martinez A, Wang R, Murday V, Shipley J, Houlston R, Harper J. 2001. PTEN mutations are uncommon in Proteus syndrome. J Med Genet 38:480-481.
2. Biesecker LG, Peters KF, Darling TN, Choyke P, Hill S, Schimke N, Cunningham M, Meltzer P, Cohen MM Jr. 1998. Clinical differentiation between Proteus syndrome and hemihyperplasia: Description of a distinct form of hemihyperplasia. Am J Med Genet 79:311-318.
3. Biesecker LG, Happle R, Mulliken J, Weksberg R, Graham JM Jr, Viljoen DL, Cohen MM Jr. 1999. Proteus syndrome: Diagnostic criteria, differential diagnosis, and patient evaluation. Am J Med Genet 84:389-395.
4. Biesecker LG, Rosenberg MJ, Vocha S, Turner JT, Cohen MM Jr. 2001, PTEN mutations and Proteus syndrome. Lancet 358:2079-2080.
5. Cohen MM Jr. 1993. Proteus syndrome: Clinical evidence for somatic mosaicism and selective review. Am J Med Genet 47:645-652
6. Cohen MM Jr, Hayden PW. 1979. A newly recognized hamartomatous syndrome. Birth Defects: Original Article Series 15(5B):291-296.
7. Cohen MM Jr, Neri G, Weksberg R. 2002. Proteus syndrome, in Overgrowth Syndromes. New York: Oxford University Press. pp 75-110.
8. Eng C, Thiele H, Zhou XP, Gorlin RJ, Hennekam RC, Winter RM. 2001. PTEN mutations and Proteus syndrome. Lancet 358:2079-2080.
9. Happle R. 1987. Lethal genes surviving by mosaiiism: A possible explanation for sporadic birth defects involving the skin. J Am Acad Dermatol 16:899-906.
10. Smith JM, Kirk EP, Theodosopoulos G, Marshall GM, Walker J, Rogers M, Field M, Brereton JJ, Marsh DJ. 2002. Germline mutation of the tumour suppressor PTEN in Proteus syndrome. J Med Genet 39:937-940.
11. Turner JT, Cohen MM Jr, Biesecker LG. 2003. Proteus syndrome: Diagnosis, misdiagnosis, and misattribution of etiology. Am J Med Genet (in press).
12. Wiedemann HR, Burgio GR, Aldenhoff P, Kunze J, Kaufmann HJ, Schirg E. 1983. The Proteus syndrome. Partial gigantism of the hands and/or feet, nevi, hemihypertrophy, subcutaneous tumors, macrocephaly, or other skull anomalies and possible accelerated growth and visceral affections. Eur J Pediatr 140:5 - 12.
13. Zhou X, Hampel H, Thiele H, Gorlin RJ, Hennekam RC, Parisi M, Winter RM, Eng C. 2001. Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes. Lancet 358:210-211.
14. Zhou XP, Marsh DJ, Hampel H, Mulliken JB, Gimm O, Eng C. 2000. Germline and germline mosaic PTEN mutations associated with a Proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arteriovenous malformations, and lipomatosis. Hum Mol Genet 9:765-768.